Medicine

Which Medications Induce Salivary Gland Dysfunction, Xerostomia, and Subjective Sialorrhea? A Systematic Review

Highlights Medication-induced salivary gland dysfunction (MISGD), xerostomia (sensation of oral dryness), and subjective sialorrhea cause significant morbidity and impair quality of life. However, no evidence-based lists of the medications that cause these disorders exist. The objective was to compile a list of medications affecting salivary gland function and inducing xerostomia or subjective sialorrhea. Data Sources Electronic databases were searched for relevant articles published until June 2013. Of 3867 screened records, 269 had an acceptable degree of relevance, quality of methodology, and strength of evidence. We found 56 chemical substances with a higher level of evidence and 50 with a moderate ...

Read More »

Screening for Poly-Drug Usage: A New Tool

My guest is Dr. Philip Britz-McKibbin, Associate Professor of Bio-analytical Chemistry at McMaster University and co-author of the article recently published in Analytical Chemistry and which details the research that led to this new method: High Throughput Screening Method for Systematic Surveillance of Drugs of Abuse by Multisegment Injection−Capillary Electrophoresis−Mass Spectrometry. In light of the epidemic of prescription drug abuse and its impact on public health, it has become imperative to develop new tools to detect and screen these abused substances. The biochemical tests that are available to our scientists today are prone to bias and are not applicable to determine a ...

Read More »

Fentanyl: What you Should Know

Dr. JoonYoung Ji returns on Oasis Discussions to speak about Fentanyl, a potent opioid that has surfaced in recent times as an abused substance responsible for many overdoses and deaths. Dr. Ji explains what Fentanyl is and why it would be found in a dental practice if ever.  We hope you find the conversation valuable and that you share your feedback with us on Oasis Discussions or through oasisdiscussions@cda-adc.ca. Bookmark our page and visit us frequently to keep up to date with the latest in the world of dentistry! Chiraz Guessaier, CDA Oasis Manager Highlights Fentanyl and carfentanyl have recently been in the ...

Read More »

Should Dentists Carry an Automated External Defibrillator in their Practice?

It is always a pleasure to host Dr. Joonyoung Ji again Oasis Discussions to speak about an increasingly important question: should dentists carry and AED in their practices. Dr. Ji spoke with Dr. John O’Keefe about few considerations that dentists might want to know.  We hope you find the conversation valuable and that you share your feedback with us on Oasis Discussions or through oasisdiscussions@cda-adc.ca. Bookmark our page and visit us frequently to keep up to date with the latest in the world of dentistry! Chiraz Guessaier, CDA Oasis Manager Highlights Automated External Defibrillators (AEDs) have become increasingly visible in ...

Read More »

Using Antibiotics Wisely to Combat Rising Drug Resistance

November 13 to 19, 2017 is World Antibiotic Awareness week. I have invited Dr. Shelita Dattani, Director, Practice Development and Knowledge Translation at the Canadian Pharmacists Association, to speak to our audience about antimicrobial resistance and stewardship. The issue is at the forefront of the World Health Organization list of priorities as rising resistance becomes gradually a global phenomenon.  Dr. Dattani spoke about how dentists and pharmacists are playing a crucial role in helping solve this issue.  We hope you find the interview informative and join our conversation. You can always share your feedback with us on Oasis Discussions or through oasisdiscussions@cda-adc.ca. Bookmark our page ...

Read More »

Oasis Case Conference: Managing a Patient with a Nasopharyngeal Carcinoma

The following conversation occurred between Drs. Paul Belzycki and Erin Watson, general Dentists in Toronto. Dr. Belzycki is a private practitioner and Dr. Watson is a dentist operating at Princess Margaret Hospital. The conversation is about the management of a patient with a nasopharyngeal carcinoma and who was treated by both Drs. Belzycki and Watson. Drs. Belzycki and Watson emphasized the importance of clearly and regularly communicating between professionals to ensure the best treatment for the patient. Dr. Belzycki is accustomed to thoroughly document his cases, a fact that Dr. Watson praised and considered instrumental for the patient’s treatment and most helpful. I ...

Read More »

ADA: Evaluation of Potentially Malignant Disorders in the Oral Cavity Clinical Practice Guideline (2017)

Adapted from the American Dental Association website A panel of experts convened by the American Dental Association (ADA) Council on Scientific Affairs presents an evidence-based clinical practice guideline called the “Evidence-Based Clinical Practice Guideline for the Evaluation of Potentially Malignant Disorders in the Oral Cavity.” The goal for this 2017 clinical practice guideline is to inform clinicians about the potential use of adjuncts as triage tools for the evaluation of lesions, including potentially malignant disorders (PMDs), in the oral cavity. Among the guideline’s recommendations: Clinicians should obtain an updated medical, social, and dental history and perform an intraoral and extraoral ...

Read More »

Oral Complications during Cancer Therapy: Bacterial Infections

Submit your question or share your feedback with us through oasisdiscussions@cda-adc.ca Highlights In this Oasis Discussions segment, Dr. Deborah Saunders and Dr. Joel Epstein discuss the management of bacterial infections in oncology patients undergoing treatment. Periodontal and odontogenic infections are commonly found worldwide. However, Periodontal pathogens may cause serious problems in cancer patients. As such, dentists play a crucial role in decontaminating patients and ensuring safe treatments for these patients. All patients should be examined prior to the cancer treatment. It is important to understand his his/her cancer diagnosis and the type of treatment he/she will be having. The work-up ...

Read More »